The primer sequences of the genes used in the RT-PCR. by Qingqing Hao (5464070)

Subjects:

Changes in mRNA expression of Caspase-3, ALDH2, Bcl-2, Bax and Bcl-2/Bax in three groups. by Qingqing Hao (5464070)

Subjects:

Comparison of myocardial LC3 immunofluorescence staining of three groups (×400, scale bar = 10μm). by Qingqing Hao (5464070)

Subjects:

The mechanism path of microcredit for poverty-alleviated population to increase farmers ‘ income. by Yin Liu (50073)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Fer-1 increased SLC7A11 and Nrf2 expression to resist <i>C. sinensis</i>-induced ferroptosis. by Haoyang Zhang (1706815)

S1 File - by Ruiming Xiao (6389546)

Subjects:

Summary of group means, standard deviations, t-statistics, and P-values. by Zoë Dinkel (21402766)

Subjects:

Fig 2 - by Ruiming Xiao (6389546)

Subjects:

Variation of active components in FCM after fermentation of probiotics. by Ruiming Xiao (6389546)

Subjects:

Fig 3 - by Ruiming Xiao (6389546)

Subjects: